Estrogen blockers in males work by either reducing the amount of estrogen the body produces or preventing estrogen from activating its receptors. The practical result is a shift in hormone balance: estrogen goes down, testosterone often goes up, and that hormonal shift can reduce breast tissue growth, improve sperm production, and address other effects of excess estrogen. These medications are used off-label in men for several specific conditions, though keeping estrogen in the right range matters, since men need some estrogen for healthy bones, brain function, and sexual health.
How Men Produce Estrogen
Men produce estrogen through an enzyme called aromatase, which converts testosterone into estrogen. This conversion happens throughout the body but is especially active in fat tissue. That’s why men with higher body fat often have elevated estrogen levels: more fat tissue means more aromatase activity, which means more testosterone gets converted into estrogen rather than staying available as testosterone.
The normal range for estradiol (the most potent form of estrogen) in adult men is 10 to 50 pg/mL. When levels climb above that range, or when the ratio of testosterone to estrogen becomes imbalanced, symptoms can appear. Breast tissue growth, reduced sex drive, difficulty with fertility, and increased belly fat are among the most common signs that estrogen is too high relative to testosterone.
Two Types of Estrogen Blockers
There are two main categories, and they work differently.
Aromatase inhibitors stop the aromatase enzyme from converting testosterone to estrogen in the first place. By blocking this conversion, they lower total estrogen levels in the body while simultaneously raising testosterone and other hormones that signal the testes to produce sperm. Anastrozole is the most commonly prescribed aromatase inhibitor for men.
Selective estrogen receptor modulators (SERMs) take a different approach. Instead of lowering overall estrogen production, they block estrogen from binding to receptors in specific tissues. Tamoxifen, for example, competes with estrogen for receptor sites in breast tissue, which is why it’s particularly effective for gynecomastia. Estrogen is still circulating in the blood, but it can’t activate those receptors to stimulate tissue growth.
The choice between the two depends on the goal. If the problem is too much estrogen overall, an aromatase inhibitor reduces production across the board. If the problem is localized, like breast tissue responding to normal estrogen levels, a SERM can block that response without lowering estrogen everywhere else in the body.
Treating Gynecomastia
Gynecomastia, the development of excess breast tissue in men, is one of the most common reasons males use estrogen blockers. The condition can cause tenderness, swelling, and self-consciousness, and it affects a substantial number of men at various life stages.
Tamoxifen is the most studied option for this use. In clinical data, it resolved gynecomastia in roughly 83% of men treated, with doses of 10 to 20 mg daily over a course of 3 to 9 months. Firm, glandular lumps responded better than fatty-type breast enlargement: 100% of glandular cases improved with tamoxifen, compared to about 63% of the fatty type. Tenderness resolved in 84% of men treated. These numbers make tamoxifen one of the more reliable non-surgical options for gynecomastia, particularly when the tissue is still relatively new and hasn’t yet become fibrotic or calcified.
Improving Male Fertility
Estrogen blockers have become an important tool for treating male infertility, even in men whose estrogen levels aren’t clearly elevated. The logic is straightforward: when an aromatase inhibitor lowers estrogen, the brain’s hormonal feedback loop responds by ramping up signals to the testes, which increases both testosterone production and sperm output.
A Cleveland Clinic study of 90 men with infertility found that anastrozole (at an average dose of 3 mg per week) produced a clinically meaningful improvement in sperm quality in 46% of patients. Nearly a third of the men, 29%, achieved normal sperm counts. Another 31% of men who had previously been ineligible for intrauterine insemination became eligible after treatment. On the other hand, about 12% experienced a decline in semen quality, so the treatment doesn’t work for everyone. Men who already had some sperm production at baseline responded far better than those starting with very low counts.
Use Alongside Testosterone Therapy
Testosterone replacement therapy (TRT) introduces extra testosterone into the body, and aromatase happily converts a portion of it into estrogen. Some men on TRT find their estrogen levels climb high enough to cause symptoms like water retention, mood changes, or breast tenderness. In these cases, a low dose of an aromatase inhibitor is sometimes prescribed alongside the testosterone to keep estrogen in check, with dosing that varies widely based on individual response and lab results.
This combination remains somewhat controversial among endocrinologists. The concern is that aggressively suppressing estrogen can cause its own set of problems, so careful monitoring through blood work is essential for men on this regimen.
Why Men Still Need Some Estrogen
Estrogen isn’t just a female hormone. Men need it for bone health, cardiovascular function, brain health, and sexual function. Suppressing estrogen too aggressively creates a different set of problems.
Bone health is the most well-documented risk. Research published in the Journal of Clinical Investigation found that men need estradiol levels above roughly 10 pg/mL to prevent increases in bone breakdown. Below about 16 pg/mL, fracture risk rises sharply in an exponential pattern. Men who take estrogen blockers long-term without monitoring can develop thinning bones and eventually osteoporosis.
Low estrogen in men also causes decreased sex drive (counterintuitively, given that these drugs raise testosterone), increased belly fat accumulation, and potential mood disturbances. The goal of treatment is never to eliminate estrogen entirely. It’s to bring the testosterone-to-estrogen ratio back into a healthy range while keeping estrogen above the thresholds the body needs for normal function.
Foods and Supplements With Mild Effects
Certain natural compounds show aromatase-inhibiting activity in laboratory studies, though their effects in the human body are far weaker than pharmaceutical options. Citrus fruits contain flavonoids, particularly in the peel, that have reduced aromatase activity by 59% to 72% in cell studies. Rosemary contains compounds that inhibit aromatase in a dose-dependent manner. Compounds found in hops and licorice can competitively inhibit aromatase in a way that resembles prescription medications at the cellular level. Resveratrol (found in red grapes) and chrysin (found in honey and passionflower) have also demonstrated inhibitory effects in lab settings.
The critical caveat is that cell-line studies and what happens inside a living human body are very different things. The concentrations needed to meaningfully suppress aromatase are often far higher than what you’d get from eating these foods or taking standard supplement doses. These compounds aren’t substitutes for medical treatment when estrogen levels are clinically elevated, but they may offer modest supporting effects as part of a broader approach that includes maintaining a healthy body weight, since reducing body fat directly reduces aromatase activity.